Prediction of intestinal drug absorption properties by three- dimensional solubility parameters

Pharmaceutical Research

Volumn 15, Issue 9, 1998, Pages 1370-1375

  Breitkreutz, Jörg ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Carrier mediated transport; Hansen solubility parameters; Passive diffusion; Regional gastrointestinal uptake; Site specific delivery; Sustained release dosage forms

Indexed keywords

ALLOPURINOL; AMPICILLIN; BETAMETHASONE; CHLORAMPHENICOL; DICOUMAROL; DIGOXIN; DOXYCYCLINE; ERYTHROMYCIN; FUROSEMIDE; GLIBENCLAMIDE; HYDROCHLOROTHIAZIDE; INDOMETACIN; ISOSORBIDE MONONITRATE; METACYCLINE; METHAQUALONE; METOPROLOL; METRONIDAZOLE; NITROFURANTOIN; OXYTETRACYCLINE; PARACETAMOL; PENICILLIN V; PHENYTOIN; PREDNISOLONE; PROPRANOLOL; PYRIDOXAL 5 PHOSPHATE; QUINIDINE; RIBOFLAVIN; SULFINPYRAZONE; TETRACYCLINE; UNINDEXED DRUG;

ACTIVE TRANSPORT; ARTICLE; DRUG ABSORPTION; DRUG DIFFUSION; DRUG RESEARCH; DRUG SOLUBILITY; HYDROGEN BOND; INTESTINE ABSORPTION; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; INTESTINAL ABSORPTION; PHARMACOKINETICS; SOLUBILITY;

EID: 0031722109     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011941319327     Document Type: Article

References (30)

1. W. I. Higuchi, N. F. H. Ho, J. Y. Park, and I. Komiya. Ratelimiting steps and factors in drug absorption. In L. F. Prescott, W. S. Nimmo, Drug absorption, MTP Press Limited, Lancaster UK, 1981, pp. 35-60.
2. N. Rouge, P. Buri, and E. Doelker. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int. J. Pharm. 136:117-139 (1996).
3. A. Tsuji and I. Tamai. Carrier-mediated intestinal transport of drugs. Pharm. Res. 13:963-977 (1996).
4. G. L. Amidon, H. Lennernäs, V. P. Shah, and J. R. Crison. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12:413-420 (1995).
5. L. X. Yu, E. Lipka, J. R. Crison, and G. L. Amidon. Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption. Adv. Drug Deliver. Rev. 19:359-376 (1996).
6. G. M. Grass. Simulation models to predict oral drug absorption from in vitro data. Adv. Drug Deliver. Rev. 23:199-219 (1997).
7. C. Hansch and J. M. Clayton. Lipophilic character and biological activity of drugs II: The parabolic case. J. Pharm. Sci. 62:1-21 (1973).
8. N. El-Tayar, R.-S. Tsai, B. Testa, P.-A. Carrupt, and A. Leo. Partitioning of solutes in different solvent systems: The contribution of hydrogen-bonding capacity and polarity. J. Pharm. Sci. 80:590-598 (1991).
9. C. M. Hansen. The universality of the solubility parameter. Ind. Eng. Chem. Res. Devel. 8:2-11 (1969).
10. B. Testa, P.-A. Carrupt, P. Gaillard, F. Billois, and P. Weber. Lipophilicity in molecular modeling. Pharm. Res. 13:335-343 (1996).
11. N. Bodor and M.-J. Huang. A new method for the estimation of the aqueous solubility of organic compounds. J. Pharm. Sci. 81:954-960 (1992).
12. J. L. Mokrosz, B. Duszynska, and L. Strekowski. Topological inidices in correlation analysis. Part 3: The modelling of hydrophobic properties using molecular connectivity and shape indices. Pharmazie 47:538-541 (1992).
13. K. Palm, P. Stenberg, K. Luthmann, and P. Artursson. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm. Res. 14:568-571 (1997).
14. R. Gröning and F.-J. Braun. Threedimensional solubility parameters and their use in characterising the permeation of drugs through the skin. Pharmazie 51:337-341 (1996).
15. R. Gröning, W. Sakran, F.-J. Braun, M. S. Adel, A: Abd El-Bary, and M. F. El-Miligi. Rectal absorption of drugs - indirect characterisation of the rectal membrane using the Bagley diagram and in vivo drug absorption data. Eur. J. Pharm. Biopharm. 42(Suppl.):55 S (1996).
16. R. F. Fedors. A method for estimating both the solubility parameters and molar volumes of liquids. Polymer Engin. Sci. 14:147-154 (1974).
17. D. W. Van Krevelen and P. J. Hoftyzer. Properties of polymers. Their estimation and correlation with chemical structures. Elsevier, Amsterdam, 1976.
18. ™ 3.1 or higher. It is available by correspondance to the author.
19. A. F. M. Barton. Solubility parameters. Chem. Rev. 75:731-753 (1975).
20. E. B. Bagley, T. P. Nelson, and J. M. Scigliano. Three-dimensional solubility parameters and their relationship to internal pressure measurements in polar and hydrogen bonding solvents. J. Paint Technol. 43:35-42 (1971).
21. R. Gröning and G. Heun. Charakterisierung der Arzneistoffabsorption aus dem Gastrointestinaltrakt mit Hilfe der numerischen Dekonvolution. Pharm. Acta Helv. 64:71-75 (1989).
22. A. H. Staib. Methods used to investigate drug absorption in the colon: A review. Workshop "Colon-Resorption und Colon-Targeting", Düsseldorf, 1996.
23. J. J. O'Brien and D. M. Campoli-Richards. Acyclovir - an updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 37:233-309 (1989).
24. J. M. Cedarbaum. Clinical Pharmacokinetics of Anti-Parkinsonian Drugs. Clin. Pharmacokin. 13:141-178 (1987).
25. W. H. Barr, E. M. Zola, E. L. Candler, S. M. Hwang, A. V. Tendolkar, R. Shamburek, B. Parker, M. D. Hilty. Differential absorption of amoxicillin from the human small and large intestine. Clin. Pharmacol. Therap. 56:279-285 (1994).
26. J. Drewe, C. Beglinger, and T. Kissel. The absorption site of cyclosporin in the human gastrointestinal tract. Br. J. Clin. Pharmac. 30:35-39 (1992).
27. D. Brockmeier, H. G. Grigleit, H. Leonhardt. The absorption of piretanide from the gastro-intestinal tract is site-dependent. Eur. J. Clin. Pharmacol. 30:79-82 (1986).
28. S. S. Davis, N. Washington, A. H. Short, V. A. John, P. Lloyd, S. M. Walker. Relationship between the rate of appearance of oxprenolol in the systemic circulation and the location of an oxprenolol oros 16/260 drug delivery system within the gastrointestinal tract as determined by scintigraphy Br. J. Clin. Pharmac. 26:435-443 (1988).
29. W. M. Meylan and P. H. Howard. Atom/fragment contribution method for estimating octanol-water partition coefficients. J. Pharm. Sci. 84:83-92 (1995).
30. R. A. Conradi, P. S. Burton, and R. T. Borchardt. Physicochemical and biological factors that influence a drug's cellular permeability by passive diffusion. In V. Pliska, B. Testa, H. van rie Waterbeemd, Lipophilicity in drug action and toxicology, VCH Verlagsgesellschaft, Weinheim, Germany, 1996 pp. 233-252.